Guanfacine NDC 24658-730

NDC codes

FDA NDC Directory

Product NDC (as listed)24658-730Labeler and product segments. Claims need a package NDC.

Product NDC at billing width24658-0730Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
24658-730-01	24658073001	100 TABLET in 1 BOTTLE (24658-730-01)Marketed from Nov 14, 2016

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Guanfacine
Generic name (nonproprietary): guanfacine
Active ingredients: Guanfacine hydrochloride — 1 mg/1
Dosage form: Tablet
Route: Oral
Labeler: PuraCap Laboratories LLC dba Blu Pharmaceuticals
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 074673
Marketing start: Nov 14, 2016
Listing expires: Dec 31, 2026
Other FDA classes: Adrenergic alpha2-Agonists (Mechanism)
Identifiers: Product ID 24658-730_51536f5a-dca8-49b1-97f4-cb6f696c4154SPL ID 51536f5a-dca8-49b1-97f4-cb6f696c4154SPL set ID ba089e4c-8623-4159-8230-5c7fd02cdb12RxCUI 197745, 197746UNII PML56A160OUPC 0324658730011, 0324658731018
Pharmacologic class: Central alpha-2 Adrenergic Agonist

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N424658073001 followed by a unit qualifier and the quantity

Package 24658-0730-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Dec 11, 2025.

Indications (excerpt from the label)

INDICATIONS AND USAGE Guanfacine hydrochloride tablets are indicated in the management of hypertension. Guanfacine may be given alone or in combination with other antihypertensive agents, especially thiazide-type diuretics.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)